Alcon

ALC

Market cap $39B

Alcon Inc. remains a global leader in eye care, benefiting from aging demographics and technological innovation, but faces valuation and growth headwinds. Recent M&A activity, including the pending STAAR Surgical deal, pressures near-term earnings and adds uncertainty, despite strategic fit. ALC shares have declined from highs, now trading at a more reasonable 25 times earnings, but growth is slowing, and valuation remains somewhat elevated.

Alcon Inc. ( ALC ) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Company Participants Daniel Cravens - Vice President of Investor Relations David Endicott - CEO & Director Timothy Stonesifer - Senior VP & CFO Conference Call Participants Anthony Petrone - Mizuho Securities USA LLC, Research Division Ryan Zimmerman - BTIG, LLC, Research Division Kavya Deshpande - UBS Investment Bank, Research Division Thomas Stephan - Stifel, Nicolaus & Company, Incorporated, Research Division Matthew Miksic - Barclays Bank PLC, Research Division David Saxon - Needham & Company, LLC, Research Division Veronika Dubajova - Citigroup Inc., Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Jack Reynolds-Clark - RBC Capital Markets, Research Division David Adlington - JPMorgan Chase & Co, Research Division Presentation Operator Greetings, and welcome to the Alcon Third Quarter 2025 Earnings Call.

Eye care firm Alcon Inc. (NYSE:ALC) on Tuesday reported third-quarter sales of $2.59 billion, up 6% year over year (up 5% constant currency), marginally missing the consensus of $2.60 billion.

Alcon posts mixed Q3 results as earnings top estimates but revenues miss; new product launches fuel optimism.

Shares rose after the eye-care specialist reported an acceleration in sales growth and confirmed its annual outlook, reassuring on its prospects after two guidance cuts this year.

Dupont (DD) is a leading specialty chemical company in the process of spinning off its electronics business, which in our view should unlock shareholder value. KKR (KKR) is a leading private equity investment firm with a large portion of earnings coming from recurring revenue sources. Alcon (ALC) revenues fell short of consensus estimates for two consecutive quarters, and management lowered its full year revenue outlook.

Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

GENEVA--(BUSINESS WIRE)--Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds.

GENEVA--(BUSINESS WIRE)--Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds.

Alibaba was a contributor to the portfolio during the quarter, driven by strong execution in its core commerce and cloud businesses, and improved investor sentiment around management's strategic direction. TSMC's management raised fiscal year 2025 guidance to 30% revenue growth year-over-year, supported by robust demand for advanced semiconductor manufacturing and strong execution across its diversified business mix. Alcon was a detractor from performance during the quarter, as the company reported weaker than expected results and lowered its 2025 revenue guidance following sluggish market conditions and competitive pressures.